Rainbow Children's Medicare Limited

BSE: RAINBOW543524ISIN INE961O01016

Healthcare
Hospital
BSE 500

Share price

₹1,278.95+31.55 (+2.53%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹1,609.00
52W low: ₹1,008.75
Off 52W high: -20.51%
1M return: +0.71%
3M return: -19.95%
6M return: -0.43%
1Y return: -8.02%
20D avg volume: 22,644
50 DMA: ₹1,338.20
200 DMA: ₹1,320.21

Key ratios Consolidated

Market cap: ₹12,990 Cr
Current price: ₹1,278.95
52W high / low: ₹1,609.00 / ₹1,008.75
Face value: ₹10.00
P/E: 43.51
P/B: 7.58
EPS (TTM): ₹29.39
Book value / share: ₹168.76
ROE: —
ROCE: 16.80%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-33.89 Cr
Interest cover: 5.62
Dividend yield: 0.27%
Dividend / share (TTM): ₹3.50
Payout: 11.91%
Cash conversion cycle: 9.4 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	548.02	469.99	459.90	445.45	444.80	352.93	370.11	398.08	417.46	330.22	341.10	335.96
	8.13	12.71	5.06	10.51	8.20	20.02	14.53	13.27	11.27	11.93	12.78	8.61
	556.15	482.69	464.96	455.96	452.99	372.94	384.63	411.36	428.73	342.15	353.88	344.57
	444.64	398.74	376.63	358.27	350.62	301.57	307.67	317.03	323.38	288.80	284.70	259.80
	73.77	64.54	56.98	60.33	62.21	47.50	47.04	53.73	51.67	42.48	41.94	42.70
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	75.18	66.85	63.07	60.06	58.78	51.62	54.32	49.31	53.75	49.00	48.41	43.42
	22.00	21.20	20.50	20.20	18.85	18.08	18.12	18.07	18.10	18.16	16.85	14.26
	44.61	42.20	40.94	39.60	35.84	34.19	34.16	35.23	34.90	34.14	32.30	27.66
	229.10	203.95	195.15	178.08	174.94	150.19	154.02	11.81	17.64	13.08	25.34	16.30
	111.50	83.95	88.33	97.69	102.37	71.37	76.97	94.33	105.35	53.35	69.17	84.77
	0.00	0.00	-1.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	111.50	83.95	86.79	97.69	102.37	71.37	76.97	94.33	105.35	53.35	69.17	84.77
	27.61	21.41	8.57	23.80	26.75	17.57	20.42	25.39	26.35	13.62	18.11	22.19
	83.89	62.54	78.22	73.90	75.62	53.80	56.55	68.94	79.00	39.73	51.06	62.57
	8.10	5.97	7.59	7.14	7.41	5.27	5.55	6.76	7.77	3.89	5.02	6.12
Key metrics
	178.11	147.35	148.23	157.49	157.06	123.64	129.25	147.63	158.35	105.65	118.32	126.69
	32.50%	31.40%	32.20%	35.40%	35.30%	35.00%	34.90%	37.10%	37.90%	32.00%	34.70%	37.70%
	15.30%	13.30%	17.00%	16.60%	17.00%	15.20%	15.30%	17.30%	18.90%	12.00%	15.00%	18.60%
	4.90%	—	4.10%	—	5.10%	—	4.30%	—	—	—	—	—
	23.20%	33.20%	24.30%	11.90%	6.50%	6.90%	8.50%	18.50%	—	—	—	—
	10.90%	16.20%	38.30%	7.20%	-4.30%	35.40%	10.80%	10.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	1,923	1,703	1,516	1,297	1,174	973.76
	36.41	43.79	51.01	37.06	30.86	18.94
	1,960	1,747	1,567	1,334	1,204	992.70
	1,578	1,387	1,237	1,039	922.66	805.35
	255.62	227.03	194.92	165.28	158.28	194.73
	0.00	0.00	0.00	—	—	—
	265.16	233.53	206.37	176.17	144.06	116.07
	83.90	77.62	72.45	59.05	55.20	53.20
	167.35	150.57	138.44	112.08	90.27	83.26
	806.28	698.35	624.69	68.28	70.99	154.32
	381.47	359.77	330.00	294.81	281.78	187.35
	-1.54	-1.54	0.00	0.00	0.00	0.00
	379.93	358.23	330.00	294.81	281.78	187.35
	81.39	76.69	85.77	76.53	69.40	48.67
	298.55	281.54	244.23	218.29	212.38	138.67
	28.80	27.41	23.97	21.38	20.89	14.75
Key metrics
	631.18	586.42	540.89	465.94	427.25	323.81
	32.82%	34.40%	35.70%	35.90%	36.40%	33.30%
	15.52%	16.50%	16.10%	16.80%	18.10%	14.20%
	—	16.80%	18.10%	—	—	—
	22.83%	12.40%	16.90%	10.50%	20.50%	—
	17.12%	15.30%	11.90%	2.80%	53.20%	—
	—	203.19	249.99	—	—	—
	—	1.49	1.62	—	—	—
	—	0.00	0.00	—	—	—
	—	-33.89	-20.25	—	—	—
	—	9.4	3.3	—	—	—
Balance sheet
	—	2,775	2,377	—	—	—
	—	662.85	832.42	—	—	—
	—	33.89	20.25	—	—	—
	—	103.18	77.30	—	—	—
	—	41.63	27.57	—	—	—
	—	25.01	17.71	—	—	—
	—	1,562	1,388	—	—	—
	—	100.57	90.97	—	—	—
	—	184.46	150.57	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	1,664	1,475	—	—	—
Cash flow
	—	419.65	395.66	—	—	—
	—	-258.65	-267.80	—	—	—
	—	-147.37	-117.72	—	—	—
	—	216.46	145.67	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	486.99	410.55	408.06	394.35	408.50	334.75	354.00	381.56	403.93	315.02	325.76	321.79
	8.09	12.76	5.24	10.76	8.17	19.29	13.89	12.85	10.72	11.48	12.23	8.24
	495.08	423.30	413.30	405.11	416.67	354.03	367.89	394.41	414.65	326.50	337.99	330.03
	395.22	352.76	333.30	316.67	318.27	285.21	293.14	302.30	311.05	274.88	269.57	247.49
	64.11	54.69	48.57	51.05	56.09	43.95	44.45	51.96	52.20	41.26	40.06	40.83
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	67.24	59.91	56.62	53.27	53.27	49.24	51.85	47.20	51.51	47.05	47.38	41.28
	19.91	19.25	18.52	18.17	17.31	17.39	17.41	17.35	17.39	17.44	16.11	13.52
	39.81	37.63	35.65	34.83	33.18	32.59	32.55	33.54	33.22	32.44	30.57	25.93
	204.15	181.29	173.94	159.35	158.41	142.04	146.88	11.52	17.21	12.78	17.43	12.21
	99.86	70.54	80.00	88.43	98.40	68.82	74.75	92.11	103.60	51.63	68.42	82.55
	0.00	0.00	-1.54	0.00	0.00	0.00	0.00	—	—	—	—	—
	99.86	70.54	78.46	88.43	98.40	68.82	74.75	92.11	103.60	51.63	68.42	82.55
	24.77	17.84	19.16	22.61	25.23	17.10	20.21	25.14	26.25	12.90	17.99	21.40
	75.09	52.71	59.30	65.82	73.17	51.72	54.54	66.97	77.34	38.73	50.44	61.14
	7.41	5.20	5.85	6.48	7.20	5.09	5.37	6.60	7.62	3.82	4.97	6.03
Key metrics
	159.58	127.42	132.63	141.43	148.89	118.80	124.71	143.00	154.21	101.51	115.10	122.00
	32.80%	31.00%	32.50%	35.90%	36.40%	35.50%	35.20%	37.50%	38.20%	32.20%	35.30%	37.90%
	15.40%	12.80%	14.50%	16.70%	17.90%	15.50%	15.40%	17.60%	19.10%	12.30%	15.50%	19.00%
	4.60%	—	3.90%	—	5.00%	—	4.20%	—	—	—	—	—
	19.20%	22.60%	15.30%	3.40%	1.10%	6.30%	8.70%	18.60%	—	—	—	—
	2.60%	1.90%	8.70%	-1.70%	-5.40%	33.50%	8.10%	9.50%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	1,700	1,546	1,455	1,237	1,114	924.60
	36.85	43.45	48.95	36.95	31.23	20.82
	1,737	1,589	1,503	1,274	1,145	945.41
	1,398	1,253	1,181	984.29	867.75	755.67
	218.42	199.67	189.87	157.13	150.12	187.80
	0.00	0.00	0.00	—	—	—
	237.04	212.39	197.61	168.71	136.04	109.41
	75.85	71.40	69.59	56.07	52.09	50.01
	147.92	136.26	131.75	105.15	83.71	76.99
	718.73	633.74	592.55	44.32	45.92	145.69
	338.83	335.65	322.08	289.22	277.46	189.74
	-1.54	-1.54	0.00	—	-4.63	—
	337.29	334.12	322.08	289.22	272.83	189.74
	84.38	84.10	84.50	74.33	66.94	47.45
	252.92	250.02	237.59	214.89	205.89	142.29
	24.94	24.62	23.40	21.17	20.40	15.18
Key metrics
	561.06	541.78	523.42	450.44	408.63	316.74
	33.00%	35.10%	36.00%	36.40%	36.70%	34.30%
	14.88%	16.20%	16.30%	17.40%	18.50%	15.40%
	—	16.40%	17.70%	—	—	—
	14.95%	6.30%	17.60%	11.00%	20.50%	—
	2.65%	5.20%	10.60%	4.40%	44.70%	—
	—	181.02	241.75	—	—	—
	—	1.52	1.62	—	—	—
	—	0.01	0.00	—	—	—
	—	-1.99	-16.89	—	—	—
	—	10.2	3.8	—	—	—
Balance sheet
	—	2,648	2,354	—	—	—
	—	596.62	795.49	—	—	—
	—	17.28	16.89	—	—	—
	—	100.35	78.46	—	—	—
	—	29.91	22.74	—	—	—
	—	23.33	16.65	—	—	—
	—	1,449	1,358	—	—	—
	—	87.40	85.88	—	—	—
	—	180.90	141.55	—	—	—
	—	15.29	0.00	—	—	—
	—	15.29	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	1,689	1,489	—	—	—
Cash flow
	—	380.91	385.05	—	—	—
	—	-241.45	-262.69	—	—	—
	—	-139.07	-112.95	—	—	—
	—	199.89	143.30	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +11.53%
Sales CAGR 5Y: —
Profit CAGR 3Y: +6.69%
Profit CAGR 5Y: —
Sales YoY (TTM): +14.95%
Profit YoY (TTM): +2.65%

Consolidated

Sales CAGR 3Y: +13.22%
Sales CAGR 5Y: —
Profit CAGR 3Y: +9.85%
Profit CAGR 5Y: —
Sales YoY (TTM): +22.83%
Profit YoY (TTM): +17.12%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 49.84%

Quarter	September 2026	June 2026
Promoter %	49.84%	49.84%

Holder	Type	Holding	Previous	Change
RAMESH KANCHARLA	Promoter	36.16%	31.03%	+5.13%
CHIRLA DINESH KUMAR PADMARAO	Promoter	6.53%	6.53%	0.00%
ADARSH KANCHARLA	Promoter	6.02%	6.02%	0.00%
ICICI PRUDENTIAL HEALTHCARE FUND	Public	5.50%	—	—
DSP FLEXI CAP FUND	Public	3.42%	—	—
FRANKLIN TEMPLETON INVESTMENT FUNDS - FRANKLIN IND	Public	2.20%	2.76%	-0.56%
HDFC LIFE INSURANCE COMPANY LIMITED	Public	2.10%	1.85%	+0.25%
ABU DHABI INVESTMENT AUTHORITY - MONSOON	Public	2.06%	2.13%	-0.07%
TITANIUM EQUITY LONG-SHORT FUND	Public	1.88%	—	—
NIPPON LIFE INDIA TRUSTEE LTD- A/C NIPPON INDIA VI	Public	1.63%	—	—
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL F	Public	1.57%	1.37%	+0.20%
MOTILAL OSWAL NIFTY SMALLCAP 250 INDEX FUND	Public	1.51%	1.26%	+0.25%
NAGALAKSHMI DEVINENI	Public	1.18%	1.18%	0.00%
PODDUTOOR PREETHAM KUMAR	Public	1.07%	—	—
CHIRLA DINESHKUMAR PADMA RAO	Promoter Group	1.02%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Apollo Hospitals Enterprises Ltd.	1,23,324	8,577.00	56.78	19.50%	+19.24% TTM	+35.20% TTM	+9.78%
Max Healthcare Institute Limited	90,129	926.00	65.28	12.70%	+15.17% TTM	+1.73% TTM	-18.59%
Manipal Health Enterprises Limited	87,828	667.70	—	—	—	—	—
ASTER DM QUALITY CARE LIMITED	62,665	718.90	172.72	10.20%	+15.70% TTM	+3.89% TTM	+4.39%
Fortis Healthcare Ltd	59,710	790.90	55.79	12.00%	+17.50% TTM	+18.62% TTM	-22.35%
Narayana Hrudayalaya Limited	39,427	1,929.30	45.89	11.40%	+71.40% TTM	+1.61% TTM	+5.41%
Global Health Limited	37,682	1,401.45	61.46	15.00%	+26.18% TTM	+9.16% TTM	+12.21%
Krishna Institute of Medical Sciences Limited	31,074	739.85	159.85	8.20%	+30.90% TTM	-51.92% TTM	+3.15%
Dr. Agarwal's Health Care Limited	16,618	524.15	89.77	9.70%	—	—	+1.80%
Rainbow Children's Medicare Limited	12,990	1,278.95	43.51	16.80%	+22.83% TTM	+17.12% TTM	-8.02%
PARK MEDI WORLD LIMITED	9,958	230.55	—	18.10%	—	—	—
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED	9,900	1,027.45	54.50	11.00%	+50.40% TTM	+19.12% TTM	+25.09%
HealthCare Global Enterprises Limited	9,286	621.95	279.19	6.90%	+13.77% TTM	-19.23% TTM	—
Jupiter Life Line Hospitals Limited	9,178	279.95	49.57	13.80%	+16.71% TTM	-6.85% TTM	-9.74%
Paras Healthcare Limited	8,135	751.85	—	—	—	—	—
Kovai Medical Center & Hospital Ltd S	6,561	5,996.35	25.97	20.60%	+14.96% TTM	+16.29% TTM	-1.95%
Artemis Medicare Services Limited	4,758	300.60	41.36	13.70%	+14.77% TTM	+21.46% TTM	+22.59%
Indraprastha Medical Corporation Lt S	3,092	337.25	16.09	30.70%	+10.72% TTM	+9.95% TTM	-44.21%
Dr.Agarwals Eye Hospital Ltd. S	2,616	5,413.80	34.33	16.10%	+20.01% TTM	+31.87% TTM	+2.39%
KMC Speciality Hospitals India Limited S	2,453	150.40	43.98	24.60%	+35.05% TTM	+137.83% TTM	+118.35%
Shalby Limited	1,336	123.70	35.06	7.90%	+7.27% TTM	+17,422.73% TTM	-49.15%
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED	1,260	159.75	75.29	8.60%	—	—	—
GPT Healthcare Limited S	1,152	140.45	24.38	16.40%	+18.07% TTM	-0.78% TTM	-5.48%
Rays of Belief Limited	528	252.45	—	—	—	—	—
ASARFI HOSPITAL LIMITED	347	176.40	—	18.40%	—	—	+22.97%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Newspaper publication of Financial Results for the quarter and half year ended September 30, 2026.2 Nov 2026 · Company Update / Newspaper Publication
Link of Audio recording of Earnings Conference Call for the quarter and half year ended September 30, 2026.2 Nov 2026 · Company Update / Analyst / Investor Meet
Press Release on Unaudited Standalone & Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026.31 Oct 2026 · Company Update / Press Release / Media Release (Revised)
Press Release on Unaudited Standalone & Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026.31 Oct 2026 · Company Update / Press Release / Media Release
Investor Presentation on Unaudited Standalone & Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026.31 Oct 2026 · Company Update / Investor Presentation
Unaudited Standalone & Consolidated Financial Results for Quarter and Half Year ended September 30, 202631 Oct 2026 · Result / Financial Results
Unaudited Standalone & Consolidated Financial Results for Quarter and Half year ended September 30, 202631 Oct 2026 · Board Meeting / Outcome of Board Meeting
Schedule of Earnings Conference Call on Unaudited Financial Results for quarter ended September 30, 2026.23 Oct 2026 · Company Update / Analyst / Investor Meet
Rainbow Children''s Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve Unaudited Financial ....23 Oct 2026 · Board Meeting / Board Meeting
Compliance Certificate Under Regulation 74(5) of SEBI (DP) Regulations, 2018.7 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of execution of lease agreement with APCRDA.30 Sep 2026 · Company Update / General
Credit Rating29 Sep 2026 · Company Update / Credit Rating
Initimation for trading window closure for quarter and half year ended September 30, 202625 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Outcome of Board Meeting for Appointment of Mr. Sudarshan Patodia as the Chief Financial Officer (KMP) of the Company and other general matters23 Sep 2026 · Others / Outcome without intimation
Intimation of contact details of Key Managerial Personnel authorised under Regulation 30(5) of SEBI (LODR) Regulations, 201523 Sep 2026 · Company Update / General
Intimation for grant of options23 Sep 2026 · Company Update / General
Appointment of Mr. Sudarshan Patodia as the Chief Financial Officer (KMP) of the Company23 Sep 2026 · Company Update / Change in Management
Update on Commencement of Operations at Guntur, Andhra Pradesh.16 Sep 2026 · Company Update / General
Intimation of Schedule of Analyst/Institutional Investor Group Meetings.11 Sep 2026 · Company Update / Analyst / Investor Meet
Resignation of Senior Management Personnel.31 Aug 2026 · Company Update / Cessation
Resignation of Mr. Vikas Maheshwari as Chief Financial Officer of the Company w.e.f. August 31, 202625 Aug 2026 · Company Update / Change in Management
Update on acquisition14 Aug 2026 · Company Update / General
Earnings Call Transcript for the quarter ended June 30, 20264 Aug 2026 · Company Update / Earnings Call Transcript
Link of Audio recording of Earnings Conference call for quarter ended June 30, 202631 Jul 2026 · Company Update / Analyst / Investor Meet
Newspaper publication of financial results for quarter ended June 30, 202631 Jul 2026 · Company Update / Newspaper Publication
Press release for the quarter ended June 30, 202630 Jul 2026 · Company Update / Press Release / Media Release
Earnings Presentation for the quarter ended June 30, 202630 Jul 2026 · Company Update / Investor Presentation
Intimation regarding grant of options under Employee Stock Option Scheme 202530 Jul 2026 · Company Update / General
Appointment as senior management personnel30 Jul 2026 · Company Update / Change in Management
Un-audited financial results (Standalone & Consolidated) for the quarter ended June 30, 202630 Jul 2026 · Board Meeting / Outcome of Board Meeting
Un-audited financial results (Standalone & Consolidated) for the quarter ended June 30, 202630 Jul 2026 · Result / Financial Results
Intimation for capacity addition29 Jul 2026 · Company Update / General
Intimation for capacity addition29 Jul 2026 · Company Update / General
Intimation for acquisition29 Jul 2026 · Company Update / Acquisition
Sale of stake29 Jul 2026 · Company Update / Restructuring
Intimation for capacity addition29 Jul 2026 · Company Update / General
Announcement under Regulation 30 (LODR) - Acquisition29 Jul 2026 · Company Update / Acquisition
Scrutinizer''s Report and voting results for the 28th Annual General Meeting for FY 2025-2629 Jul 2026 · AGM/EGM / AGM
Proceedings of the 28th Annual General Meeting for FY 2025-2629 Jul 2026 · AGM/EGM / AGM
Earnings Conference Call for discussion on financial results declared for quarter ended June 30, 202623 Jul 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 3.5000	21 Jul 2026	21 Jul 2026	—
Final Dividend - Rs. - 3.0000	27 Jun 2025	28 Jun 2025	—
Final Dividend - Rs. - 3.0000	23 Jul 2024	23 Jul 2024	—

Board meetings

31 Oct 2026 Board Meeting - Financial Results
30 Jul 2026 Board Meeting - Financial Results